USPTO serial 87871539
ACCREDO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 28, 2019
- Examiner
- HOPKINS II, DEAN ANDREW
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with ACCREDO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Express Scripts Strategic Development, Inc.
St. Louis, MO
Other trademarks owned by Express Scripts Strategic Development, Inc.
Express Scripts Strategic Development, Inc.
St. Louis, MO
Other trademarks owned by Express Scripts Strategic Development, Inc.
Express Scripts Strategic Development, Inc.
St. Louis, MO
Other trademarks owned by Express Scripts Strategic Development, Inc.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Troy E. Larson
1601 Chestnut Street, TL7Two Liberty PlacePhiladelphia, PA 19192Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | resources appropriate for support of disease management, namely downloadable electronic publications in the nature of brochures, booklets and newsletters related to the support of disease management | ACTIVE | — |
| 035 | mail order pharmacy services specializing in the treatment and control of chronic diseases and specialty medications; mail order pharmacy services specializing in the control of hemophilia | ACTIVE | Oct 18, 2008 |
| 041 | Providing patient educational services, namely, conducting programs in the field of chronic diseases and specialty medications, and distributing course materials in connection therewith and providing patient educational services, namely, conducting programs in the field of proper product-reconstitution and administration; providing resources appropriate for support of disease management, namely, providing a website featuring non-downloadable publications in the nature of brochures and newsletters related to the support of disease management; providing a website featuring non-downloadable videos related to the support of disease management; educational services for product manufacturers, pharmaceutical clinicians and biotech companies, clinicians, contract research organizations and insurance providers, namely, conducting classes, one-on-one sessions and telephonic workshops in the field of clinical education and distributing course materials in connection therewith; educational services, namely, classes, one on one sessions and telephonic workshops which provide physicians, insurance companies and patients with specific characteristics associated with disease management products; educational services and resources, namely, conducting workshops for children to help them understand hemophilia; educational services, namely, conducting workshops for children to help them understand hemophilia and other chronic conditions and diseases | ACTIVE | Oct 18, 2008 |
| 044 | Nursing care specializing in the treatment, prevention and control of chronic diseases, and nursing care services related to specialty medications; nursing care specializing in the treatment, prevention and control of hemophilia; medical services, namely, administration of pharmaceutical preparations used in the treatment of chronic diseases and administration of pharmaceutical preparations used in the treatment of hemophilia; administration of pharmaceutical preparations used in the treatment of chronic diseases; nursing and pharmacy care services, namely, disease management services; telephone hotline counseling, namely, offering healthcare advice; services consisting of providing nutritional guidance and consultation to chronically ill patients; providing educational information about nursing and pharmacy care services, namely, providing resources appropriate for support of disease management | ACTIVE | Oct 18, 2008 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Express Scripts Strategic Development, Inc.
- Other trademarks owned by Express Scripts Strategic Development, Inc.
- Other trademarks owned by Express Scripts Strategic Development, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 044
- Similar marks named ACCREDO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 19, 2025 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Sep 19, 2025 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Sep 19, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 8, 2025 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Sep 25, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 25, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 25, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 28, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jun 4, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 4, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 28, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 12, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 12, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 20, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 1, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jan 17, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 17, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 17, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 17, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 17, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 16, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 15, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 15, 2019 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Sep 4, 2018 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 4, 2018 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 4, 2018 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 24, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 23, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 23, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 30, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 30, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 30, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 27, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 19, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 13, 2018 | NWAP | NEW APPLICATION ENTERED | — |